COMPLANT(000151)2021-08-13 16:00Financial Performance - The company's operating revenue for the first half of 2021 was ¥183,053,547.74, a decrease of 53.29% compared to ¥391,879,193.35 in the same period last year[20]. - The net profit attributable to shareholders was -¥39,717,076.46, representing a decline of 577.13% from a profit of ¥8,324,173.04 in the previous year[20]. - The net cash flow from operating activities was -¥154,543,626.26, a significant drop of 269.59% compared to ¥91,127,476.08 in the prior year[20]. - The basic and diluted earnings per share were both -¥0.1342, a decrease of 577.58% from ¥0.0281 in the same period last year[20]. - Operating profit was reported at -¥37,456,320.42, reflecting a decline of 512% year-on-year[27]. - The total operating revenue for the reporting period was CNY 183,053,547.74, a decrease of 53.29% compared to CNY 391,879,193.35 in the same period last year[36]. - The net loss for the first half of 2021 was CNY 39,717,076.46, compared to a net profit of CNY 8,324,173.04 in the same period of 2020[142]. - The total comprehensive income for the first half of 2021 was -26,802,006.01 CNY, compared to 11,311,093.25 CNY in the same period of 2020, indicating a significant decline[146]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,910,678,652.19, an increase of 5.86% from ¥1,804,951,349.05 at the end of the previous year[20]. - The total liabilities decreased to ¥1,064,311,105.66 from ¥1,167,387,508.60, a reduction of approximately 8.8%[134]. - Owner's equity increased to ¥846,367,546.53, compared to ¥637,563,840.45 at the end of 2020, marking a significant increase of about 32.7%[135]. - The company's total liabilities decreased to CNY 1,027,185,143.24 in the first half of 2021 from CNY 1,137,351,919.28 in the previous year, a reduction of 9.7%[140]. - The company's short-term borrowings decreased by 3.25% to CNY 256,153,339.05, primarily due to loan repayments during the reporting period[41]. Cash Flow - The net cash flow from operating activities for the first half of 2021 was -154,543,626.26 CNY, a decrease from 91,127,476.08 CNY in the first half of 2020[149]. - Cash inflows from operating activities totaled 213,465,546.87 CNY, down from 618,323,716.59 CNY year-over-year, reflecting a 65.5% decrease[149]. - Cash outflows from operating activities increased to 368,009,173.13 CNY, compared to 527,196,240.51 CNY in the previous year, representing a 30.2% increase[149]. - The net cash flow from financing activities was 166,879,701.40 CNY, a turnaround from -133,997,093.79 CNY in the first half of 2020[150]. Business Strategy and Focus - The company is focusing on environmental business as a new growth point, supported by its controlling shareholder, Zhongcheng Group[26]. - The company is actively adjusting its business structure and increasing market development efforts along the Belt and Road Initiative[26]. - The company plans to focus on market expansion and new product development in the upcoming quarters[159]. - The company has initiated a strategy for potential mergers and acquisitions to enhance its market position[159]. Legal Matters - The company is involved in significant litigation matters, with a claim amounting to 44,725,886.44 CNY related to a contract dispute with Shanghai Yueyang Steel Co., Ltd.[79]. - The company has a pending arbitration case with KARFILED INVESTMENTS LIMITED regarding the KESEM sugar factory project in Ethiopia, which has not yet gone to court[81]. - The company has previously reached a mediation agreement with Shanghai Yueyang Steel Co., Ltd. but has faced challenges in recovering certain advance payments[79]. - The company continues to engage in legal strategies to protect its interests in ongoing disputes[79]. Shareholder Information - The total number of shares increased from 295,980,000 to 337,370,728 following the issuance[108]. - The largest shareholder, China Complete Equipment Import & Export Group Co., Ltd., holds 39.79% of the shares, totaling 134,252,133 shares[118]. - The company reported no changes in the shareholding of directors, supervisors, and senior management during the reporting period[120]. - The company’s stock was listed on the Shenzhen Stock Exchange on June 9, 2021[108]. Research and Development - Research and development expenses increased by 363.56% to CNY 193,300.00, mainly due to increased expenditures on the microbial agent project[34]. - The company reported a fair value gain of CNY 5,657,437.50 in the first half of 2021, with no such gain reported in the same period of 2020[140]. Compliance and Governance - The financial report for the half-year period is unaudited[130]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring compliance and transparency in financial reporting[172]. - The company maintains a continuous operating capability for at least 12 months from the reporting date[170].